Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07648316

Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotional Well-Being in Young Healthy Adults

College students face substantial and persistent mental health challenges that directly affect cognitive performance, stress regulation, and emotional well-being. Neurological functions such as working memory, attention regulation, executive control, and emotional processing are highly sensitive to stressors, leaving young adults vulnerable to daily fluctuations in cognitive efficiency. Recent findings from the Healthy Minds Network (2025) indicate that although rates of moderate to severe depression among college students declined from 44% in 2022 to 37% in 2025, and anxiety symptoms fell from 37% to 32%, levels of psychological flourishing also dropped, falling to 36% despite these improvements.

Ginseng contains bioactive compounds known as ginsenosides that favorably influence brain function and inflammatory cascades. Studies in stressed and moderately stressed adults demonstrated reduced perceived stress, improved emotional processing, enhanced cognitive performance, and beneficial changes to biomarkers with ginseng supplementation. In addition, randomized controlled trials reported improvements in mood regulation, fatigue resistance, and aspects of working memory and attention following short-term ginseng supplementation. This study will examine the effects of daily red panax ginseng supplementation (3000 mg/day; two 1500 mg Red Panax gummies) on cognitive performance and emotional well-being in healthy young adults.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

College students face substantial and persistent mental health challenges that directly affect cognitive performance, stress regulation, and emotional well-being. Neurological functions such as working memory, attention regulation, executive control, and emotional processing are highly sensitive to stressors, leaving young adults vulnerable to daily fluctuations in cognitive efficiency. Recent findings from the Healthy Minds Network (2025) indicate that although rates of moderate to severe depression among college students declined from 44% in 2022 to 37% in 2025, and anxiety symptoms fell from 37% to 32%, levels of psychological flourishing also dropped, falling to 36% despite these improvements.

Ginseng contains bioactive compounds known as ginsenosides that favorably influence multiple neurobiological pathways such as neurotrophic signaling, neurotransmitter regulation, oxidative balance, and inflammatory cascades. Studies in stressed and moderately stressed adults demonstrated reduced perceived stress, improved emotional processing, enhanced cognitive performance, and modulated biomarkers related to the hypothalamic-pituitary-adrenal axis with ginseng supplementation. In addition, randomized controlled trials reported improvements in mood regulation, fatigue resistance, and aspects of working memory and attention following short-term ginseng supplementation. This study will examine the effects of daily red panax ginseng supplementation (3000 mg/day; two 1500 mg Red Panax gummies) on cognitive performance and emotional well-being in healthy young adults.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy young adults
  • 18-30 years of age

Exclusion criteria

  • medication/drug use that has not been consistent for the previous 3 months or will be discontinued during the trial
  • unresolved chronic medical conditions (e.g., presence of persistent symptomology)
  • diagnosed clinical depression
  • acute illness
  • regular use of cigarettes or marijuana
  • pregnant or lactating women
  • not fluent in English
  • currently competing in sports or unusually high-intensity exercise protocols (e.g., high-intensity exercise greater than 30 minutes most days of the week)
  • current use of ginseng or adaptogenic supplements, or allergy to ginseng
  • any significant food allergies
  • not willing to attend two in-person lab visits in downtown Phoenix and follow study protocol (including abstaining from caffeine in the 12 hours prior to testing)

Treatment and study plan

Ginseng

Dietary Supplement

This study will test the efficacy of ginseng on health compared to placebo treatment.

Placebo

Dietary Supplement

This study will test the efficacy of ginseng on health compared to placebo treatment.

Primary outcomes

  1. cognitive performance

    Time frame: 2 hours post ingestion

    Trail Making Test: measures cognitive flexibility; visual attention, and executive function, with interpretation based on completion times (in seconds)

  2. cognitive performance

    Time frame: 2 weeks

    Trail Making Test measures cognitive flexibility; visual attention, and executive function, with interpretation based on completion times (in seconds)

Secondary outcomes

  1. stress

    Time frame: 2 weeks

    Perceived Stress Scale: higher scores indicate higher stress

  2. mental well being

    Time frame: 2 weeks

    Warwick-Edinburgh Mental Well-Being Scale: higher scores indicating greater positive mental wellbeing

Other outcomes

  1. cognitive performance

    Time frame: 2 hours post ingestion

    Stroop test: measures attention span, reaction time, and ability to resist distractions

  2. cognitive performance

    Time frame: 2 hours post ingestion

    reaction time test: measured by the elapsed time between stimulus onset and an individual's response

Study contacts

Contact information is provided by the study sponsor or research team.

Carol Johnston

CONTACT

[email protected]

6024963463

Sponsors and collaborators

Lead sponsor

Arizona State University

Other

Registry information

Official study title

Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotional Well-Being in Young Healthy Adults, a Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jun 15, 2026
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.